Minimizing atrial pacing does not prevent atrial fibrillation in patients with sinus node dysfunction, according to late-breaking research presented in a Hot Line session today at ESC Congress 2023.

This story is part of a series on the current progression in Regenerative Medicine. This piece discusses the regeneration of the cardiovascular system. In 1999, I defined regenerative medicine as the ...

Subclinical atrial fibrillation is short-lasting and asymptomatic and can usually be detected only by long-term continuous monitoring with pacemakers or defibrillators. Subclinical atrial fibrillation ...

Harish Manyam, MD, chief of cardiology at Erlanger and Chair of Medicine for the University of Tennessee Health Science Center College of Medicine – Chattanooga, completed Tennessee’s first atrial ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW ORLEANS -- A ...

LOS ANGELES – The Registry of Atrial Tachycardia and Atrial Fibrillation Episodes in the Cardiac Rhythm Management Device Population (RATE) shows that long episodes of atrial tachycardia or atrial ...

The Aveir DR dual-chamber leadless pacemaker system (Abbott) performs well out to 1 year in patients largely treated for sinus node dysfunction or atrioventricular (AV) block, according to extended ...

Patients who require a new permanent pacemaker after TAVI do just as well with leadless devices out to 2 years as they do with transvenous pacemakers, according to an analysis of real-world data from ...